These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15762182)

  • 1. Subclinical hyperthyroidism: clinical features and treatment options.
    Biondi B; Palmieri EA; Klain M; Schlumberger M; Filetti S; Lombardi G
    Eur J Endocrinol; 2005 Jan; 152(1):1-9. PubMed ID: 15762182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
    Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
    Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.
    Biondi B; Fazio S; Carella C; Sabatini D; Amato G; Cittadini A; Bellastella A; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1994 May; 78(5):1028-33. PubMed ID: 8175955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
    Pfeilschifter J; Ziegler R
    Eur J Endocrinol; 1997 Jan; 136(1):81-6. PubMed ID: 9037131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade.
    Fazio S; Biondi B; Carella C; Sabatini D; Cittadini A; Panza N; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2222-6. PubMed ID: 7608283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on subclinical hyperthyroidism.
    Donangelo I; Braunstein GD
    Am Fam Physician; 2011 Apr; 83(8):933-8. PubMed ID: 21524033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
    Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
    Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thyroid hormone on the cardiovascular system.
    Fazio S; Palmieri EA; Lombardi G; Biondi B
    Recent Prog Horm Res; 2004; 59():31-50. PubMed ID: 14749496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subclinical thyroid dysfunction on the heart.
    Biondi B; Palmieri EA; Lombardi G; Fazio S
    Ann Intern Med; 2002 Dec; 137(11):904-14. PubMed ID: 12458990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
    Faber J; Wiinberg N; Schifter S; Mehlsen J
    Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subclinical hyperthyroidism].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2007; 58(6):536-42. PubMed ID: 18205111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study.
    Smit JW; Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bleeker GB; Holman ER; van der Wall EE; Romijn JA; Bax JJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6041-7. PubMed ID: 16131580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
    Sgarbi JA; Villaça FG; Garbeline B; Villar HE; Romaldini JH
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
    Lerch M; Meier C; Staub JJ
    Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
    Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclinical thyroid disease--should we treat, should we screen for it?].
    Trbojević B
    Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Subclinical Iatrogenic Hyperthyroidism in the Setting of Heart Disease and Arrhythmic Burden.
    Mastroianno S; Di Stolfo G; Maggio A; Pacilli M; Potenza DR; Massaro R; De Luca G; Russo A
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):959-962. PubMed ID: 31880254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.